Ironwood Pharmaceuticals | IRWD - Trade Creditors


Ironwood Pharmaceuticals reported $1.61M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Almirall EUR 258.05M 58.66M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 45.36M 8.64M Dec/2025
Ardelyx USD 19.24M 845K Dec/2025
Astellas Pharma JPY 181.95B 13.3B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Charles River Laboratories USD 148.8M 20.82M Dec/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Lexicon Pharmaceuticals USD 3.08M 714K Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Moderna USD 317M 50M Dec/2025
Myriad Genetics USD 30M 1.8M Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Takeda JPY 467.59B 28.61B Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024